This Article Full Text Full Text (PDF) All Versions of this Article: 90/8/4880    most recent Author Manuscript (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reynaud, R. Articles by Brue, T. Search for Related Content PubMed PubMed Citation Articles by Reynaud, R. Articles by Brue, T. Related Collections Female Endocrinology Male Endocrinology Neuroendocrinology and Pituitary

An Uncommon Phenotype with Familial Central Hypogonadism Caused by a Novel PROP1 Gene Mutant Truncated in the Transactivation Domain

Laboratoire des Interactions Cellulaires Neuro-Endocriniennes (R.R., A.B., S.V.-K., A.S., M.-P.G., A.E., T.B.), Unité Mixte de Recherche 6544 Centre National de la Recherche Scientifique, Université de la Méditerranée, Institut Fédératif de Recherche Jean-Roche, Faculté de Médecine Nord, 13926 Marseille, France; Departments of Pediatrics (R.R., G.S.), and Endocrinology (A.B., A.S., T.B.), Centre Hospitalo-Universitaire Timone, Laboratoire de Biochimie et Biologie Moléculaire (A.B., A.S., A.E.), Hôpital de la Conception, 13385 Marseille Cedex, France; and Department of Endocrinology, Hôpital Jean Verdier (P.V.), Assistance Publique-Hôpitaux de Paris, 93143 Bondy Cedex, France

Address all correspondence and requests for reprints to: Thierry Brue, M.D., Ph.D., Hôpital de la Timone, 264 rue St. Pierre, 13385 Marseille Cedex 5, France. E-mail: thierry.brue{at}mail.ap-hm.fr.

Context: PROP1 gene mutations are usually associated with childhood onset GH and TSH deficiencies, whereas gonadotroph deficiency is diagnosed at pubertal age.

Objectives: We report a novel PROP1 mutation revealed by familial normosmic hypogonadotropic hypogonadism. We performed in vitro transactivation and DNA binding experiments to study functional consequences of this mutation.

Setting: Three brothers were followed in the Department of Endocrinology of a French university hospital.

Patients: These patients from a consanguineous kindred were referred for cryptorchidism and/or delayed puberty.

Results: Initial investigations revealed hypogonadotropic hypogonadism. One of the patients had psychomotor retardation, intracranial hypertension, and minor renal malformations. The brothers reached normal adult height and developed GH and TSH deficiencies after age 30. A novel homozygous nonsense mutation (W194X) was found in the PROP1 gene, indicating that the protein is truncated in its transactivation domain. Transfection studies confirmed the deleterious effect of this mutation, whose transactivation capacity was only 34.4% of that of the wild-type. Unexpectedly altered DNA-binding properties suggested that the C-terminal end of the factor plays a role in protein-DNA interaction.

Conclusions: PROP1 mutations should be considered among the growing number of genetic causes of initially isolated hypogonadotropic hypogonadism. This report extends the phenotype variability associated with PROP1 mutations.

This article has been cited by other articles:

				F. Castinetti, A. Saveanu, R. Reynaud, M. H. Quentien, A. Buffin, R. Brauner, N. Kaffel, F. Albarel, A. M. Guedj, M. El Kholy, et al. A Novel Dysfunctional LHX4 Mutation with High Phenotypical Variability in Patients with Hypopituitarism J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2790 - 2799. [Abstract] [Full Text] [PDF]

				D. Kelberman and M. T. Dattani Hypothalamic and pituitary development: novel insights into the aetiology Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S3 - S14. [Abstract] [Full Text] [PDF]

				A. Barlier, J.-F. Vanbellinghen, A. F. Daly, M. Silvy, M.-L. Jaffrain-Rea, J. Trouillas, G. Tamagno, L. Cazabat, V. Bours, T. Brue, et al. Mutations in the Aryl Hydrocarbon Receptor Interacting Protein Gene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1952 - 1955. [Abstract] [Full Text] [PDF]

				R. Reynaud, M. Gueydan, A. Saveanu, S. Vallette-Kasic, A. Enjalbert, T. Brue, and A. Barlier Genetic Screening of Combined Pituitary Hormone Deficiency: Experience in 195 Patients J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3329 - 3336. [Abstract] [Full Text] [PDF]